美国的制药巨头默克公司2004年因安全丑闻将其恶名昭著的止痛药万络召回,随后,迪克·克拉克出任公司董事长。
The chairman of Merck, a giant American drugs firm, got the top job after a safety scandal caused Vioxx, the firm's blockbuster painkiller, to be pulled from the market in 2004.
一家于2008年转向生物仿制制药的美国制药公司---默克公司认为进入生物仿制制药这个领域的障碍是如此之大以至于“只有几家”公司有能力成功进入。
Michael Kamarck of Merck, an American drugs firm which moved into biosimilars in 2008, thinks the barriers to entry are so great that “only a handful” of firms will be able to pull it off.
Nissen博士,这位美国知名的心脏病专家,激烈的反对两个美国大型制药公司默克和先灵葆雅对Vytorin(一种由这两家公司联合研制的重磅炸弹级别的抗胆固醇的处方药)的临床试验所采取的做法。
Dr Nissen, a leading cardiologist, is up in arms over the way Merck and Schering-Plough, two American pharmaceutical giants, have handled a clinical trial of Vytorin, a blockbuster anticholesterol
应用推荐